DOAC

EP 105: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Listen time: 1h 3m 40s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Watch time: 1h 5m 20s

Minh That Ton , Tri Huynh Quang Ho , Viet Lan Nguyen , et al

Read time: 18m

Tri Huynh Quang Ho , Minh That Ton , Viet Lan Nguyen , et al

Read time: 18m
CardioNerds @AHA23: ARTESiA: Stroke Risk Reduction in Sub-Clinical AF: Apixaban vs Aspirin

Naima Maqsood, Jeff Healey,

Watch time: 11m 15s

Azfar Zaman , Bernard Prendergast , David Hildick-Smith , et al

Read time: 14 Mins

Brian Zenger , Scott Rizzi , Benjamin A Steinberg , et al

Read time: 20 Mins
ESC 22: 3 Trials That Will Change Your Practice With Dr Afzal Sohaib

Afzal Sohaib,

Watch time: 3m 29s
ESC 22: APOLLO: Apixaban for Prevention of Thromboembolic Outcomes in COVID

Renato D Lopes,

Watch time: 3m 57s
ESC 22: ACT: Anti-Coronavirus Therapies to Prevent Progression of COVID-19

Sanjit Jolly,

Watch time: 4m 59s
ESC 22: Milvexian in Addition to Aspirin ＆ Clopidogrel for Secondary Stroke

Mukul Sharma,

Watch time: 6m 26s
ESC 22: Dosing of Asundexian in Pts With Non-Cardioembolic Ischemic Stroke

Ashkan Shoamanesh,

Watch time: 7m 9s

Andreas Goette , Hein Heidbuchel ,

Julia Sikorska , James Uprichard ,

Georg Nickenig, Todd Villines, Christopher P Cannon, et al

Pascal Vranckx , Marco Valgimigli , Hein Heidbuchel ,

David Hildick-Smith, Tim Betts, A John Camm, et al

Watch time: 1h 32m 45s

Doreen Su-Yin Tan, Gheorghe-Andrei Dan, Oskars Kalējs, et al

Watch time: 1h 1m 55s

Alex Spyropoulos, Gary E Raskob,

Watch time: 1h 2m 6s

Daniel TT Chong , Felicita Andreotti , Peter Verhamme , et al

Read time: 15m

Payam Pournazari , Su Min Chang , Stephen H Little , et al

Sotiris Antoniou , Bernard Man Yung Cheung, Sang Hong Baek, et al

Watch time: 6h 2m 18s (6 videos)

Brian Zenger , Scott Rizzi , Benjamin A Steinberg , et al

Read time: 20 Mins

Philipp Bushoven , Sven Linzbach , Mate Vamos , et al

Media

ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan,

Watch time: 17m 13s

Doreen Su-Yin Tan, Gheorghe-Andrei Dan, Oskars Kalējs, et al

Watch time: 1h 1m 55s

Sotiris Antoniou , Bernard Man Yung Cheung, Sang Hong Baek, et al

Watch time: 6h 2m 18s (6 videos)
ACC 22: ADAPT-TAVR Shows SLT Does Not Affect CO for Patients After TAVR

Duk-Woo Park,

Watch time: 7m 44s
ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI

George D Dangas,

Watch time: 6m 33s

David Hildick-Smith, Tim Betts, A John Camm, et al

Watch time: 1h 32m 45s
TCT Connect 2020 Discussion: The VOYAGER PAD Study

Mirvat Alasnag, Connie N Hess,

Watch time: 17m 13s
PART 1: RE-DUAL PCI – Switching Of NOACs

Jur ten Berg,

Watch time: 12m 32s

Jur ten Berg, Christopher P Cannon,

Watch time: 23m 40s (2 videos)
AHA 2019: Clinical Data Update on TWILIGHT and TWILIGHT-ACS

Marc P Bonaca, Roxana Mehran,

Watch time: 5m 5s
NOAC's in Non-valvular Atrial Fibrillation Patients Undergoing PCI

Robert A Byrne, Georg Nickenig,

Watch time: 30m 6s
NOAC's in non-valvular atrial fibrillation patients undergoing PCI - GERMAN

Stefan H Hohnloser, Georg Nickenig,

Watch time: 20m 21s

Media

Cardiovascular Outcomes For People Using Anticoagulation Strategies At ESC 2017 discuss with Professor Eugene Braunwald

Eugene Braunwald, Afzal Sohaib,

Watch time: 8m 50s
Parallax: The Year 2023 in Review with Dr Sukh Nijjer

Ankur Kalra, Sukhjinder Nijjer,

Watch time: 1h 5m 20s

Ignacio Cruz, Jens Erik Nielsen Kudsk, Prof Henning Ebelt, et al

Watch time: 2h 5m 51s

David Hildick-Smith, Tim Betts, A John Camm, et al

Watch time: 1h 32m 45s

A John Camm, Paulus Kirchhof, Raffaele De Caterina, et al

HRS 2020: Incidence of Silent Brain Infarcts in Anticoagulated Patients with AF

David Conen,

Watch time: 7m 38s
CardioNerds @AHA23: ARTESiA: Stroke Risk Reduction in Sub-Clinical AF: Apixaban vs Aspirin

Naima Maqsood, Jeff Healey,

Watch time: 11m 15s

Doreen Su-Yin Tan, Gheorghe-Andrei Dan, Oskars Kalējs, et al

Watch time: 1h 1m 55s

Jens Erik Nielsen Kudsk, A John Camm, Vivek Reddy, et al

Watch time: 51m 8s

Pablo Avanzas, Román Freixa Pamias, Antoni Martínez-Rubio, et al

Watch time: 28m 4s

Alex Spyropoulos, Gary E Raskob,

Watch time: 1h 2m 6s

Philip J Devereaux, John Eikelboom,

Watch time: 17m 25s

Articles

Prospective and Centralized Follow-Up of a Territorial Protocol of Use of Direct Oral Anticoagulants in Non Valvular Atrial Fibrillation

Fernando Worner

,

Cristina Marzo

,

Kristian Rivera

,

Nuria Sans

,

Ainara Ferrero

,

Joan Antoni Schoenenberger

,

Leonardo Galván

,

Albina Aldomà

,

Citation:

European Cardiology Review 2017;12(2):108.

DOI:

https://doi.org/10.15420/ecr.2017:23:17
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 304
  • Downloads: Downloads 2

Drug–Drug and Drug–Food Interactions of Oral Anticoagulation

Pascal Vranckx

,

Marco Valgimigli

,

Hein Heidbuchel

,

Citation:

Arrhythmia & Electrophysiology Review 2018;7(1):55–61.

DOI:

https://doi.org/10.15420/aer.2017.50.1
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 5689
  • Downloads: Downloads 58
  • Citations: 88

Oral Anticoagulants in Atrial Fibrillation

Antoni Martínez-Rubio

,

Mario DiazNuila-Alcazar

,

Anna Soria Cadena

,

Roger Martínez-Torrecilla

,

Published:

22 December 2016

Citation:

European Cardiology Review 2016;11(2):118–22

DOI:

https://doi.org/10.15420/ecr.2016:30:1
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1111
  • Downloads: Downloads 13
  • Citations: 3

Cardiovascular Pharmacotherapies Focus: Are low doses of direct-acting oral anticoagulants justified and appropriate in patients with nonvalvular atrial fibrillation?

Antoni Martínez-Rubio

,

Gheorghe-Andrei Dan

,

Citation:

European Cardiology Review 2016;11(2):115–7

DOI:

https://doi.org/10.15420/ecr.2016.11.2.ED2
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1081
  • Downloads: Downloads 15